117 results on '"Zhang, Kam Y.J."'
Search Results
2. The Ser7 of RNA Pol II-CTD influences the recruitment of Cdc73 for mRNA transcription
3. The Saccharomyces cerevisiae SR protein Npl3 interacts with hyperphosphorylated CTD of RNA Polymerase II
4. Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy
5. Crystal structure of human acetylcholinesterase in complex with tacrine: Implications for drug discovery
6. An integrated protein structure fitness scoring approach for identifying native-like model structures
7. A comprehensive characterization of novel CYP-BM3 homolog (CYP-BA) from Bacillus aryabhattai
8. Contributors
9. Molecular dynamics simulations: Principles, methods, and applications in protein conformational dynamics
10. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation
11. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
12. ATP7A Clinical Genetics Resource – A comprehensive clinically annotated database and resource for genetic variants in ATP7A gene
13. The Ser7 of RNA Pol II-CTD influences the recruitment of Cdc73 for mRNA transcription
14. Population-Based Sampling and Fragment-Based De Novo Protein Structure Prediction
15. A community effort to discover small molecule SARS-CoV-2 inhibitors
16. Supplementary Tables S1-S2 and Figures S1-S15 from The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide
17. Data from The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide
18. Data from EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer
19. Supplementary Methods from EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer
20. Supplementary Figures S1-10 and Table S1 from EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer
21. Supplementary methods from The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide
22. A novel structure-based approach for identification of vertebrate susceptibility to SARS-CoV-2: Implications for future surveillance programmes
23. Targeting LIF/LIFR signaling in cancer
24. Corrigendum to “Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2” [Microbial Pathog. 145 (2020) 104236]
25. Identification of 1,2,4‐Triazolylthioethanone Scaffold for the Design of New Acetylcholinesterase Inhibitors
26. Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
27. Understanding the molecular interactions of inhibitors against Bla1 beta-lactamase towards unraveling the mechanism of antimicrobial resistance
28. Chemical similarity assisted search for acetylcholinesterase inhibitors: Molecular modeling and evaluation of their neuroprotective properties
29. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
30. Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors
31. Biophysical characterization of recombinant human Bcl-2 and its intractions with an inhibitory ligand, antimycin A
32. Actin R256 Mono-methylation Is a Conserved Post-translational Modification Involved in Transcription
33. Design of a Peptide-Based Subunit Vaccine against Novel Coronavirus SARS-CoV-2
34. Crystal Structure of Phosphodiesterase Families and the Potential for Rational Drug Design
35. Keynote review: Phosphodiesterase-4 as a therapeutic target
36. Multidimensional Histograms for Density Modification
37. Mutation and modeling analysis of the Saccharomyces cerevisiae Swi6 ankyrin repeats
38. [4] Combining constraints for electron-density modification
39. Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer’s disease
40. EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer
41. Balancing exploration and exploitation in population-based sampling improves fragment-based de novo protein structure prediction
42. Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping
43. Fragger: a protein fragment picker for structural queries
44. Fragger: a protein fragment picker for structural queries
45. Balancing exploration and exploitation in population-based sampling improves fragment-basedde novoprotein structure prediction
46. Discovery of a Compound That Inhibits IRE1α S-Nitrosylation and Preserves the Endoplasmic Reticulum Stress Response under Nitrosative Stress
47. Identification of quinazolinyloxy biaryl urea as a new class of SUMO activating enzyme 1 inhibitors
48. The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide
49. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives
50. Characterization of pH-induced transitions of Entamoeba histolytica d-phosphoglycerate dehydrogenase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.